Attached files
| file | filename |
|---|---|
| 8-K - CURRENT REPORT - Protara Therapeutics, Inc. | ea119830-8k_artarathera.htm |
Exhibit 16.1
March 23, 2020
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Ladies and Gentlemen:
We have read Item 4.01 of Form 8-K dated March 23, 2020, of ArTara Therapeutics, Inc. and are in agreement with the statements contained in the paragraph 3 on page 2 therein. We have no basis to agree or disagree with other statements of the registrant contained therein.
/s/ Ernst & Young LLP
